comparemela.com
Home
Live Updates
Inherited Cardiomyopathies - Breaking News
Pages:
Latest Breaking News On - Inherited cardiomyopathies - Page 1 : comparemela.com
Rocket Pharmaceuticals to Present Updated Data from Phase 1 Danon Disease Trial for RP-A501 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
— Updated Data from Phase 1 Danon Disease trial expected to include efficacy and safety data from pediatric cohort and longer-term data from adult cohort — — Company to webcast. | September 16, 2022
United states
Joseph rossano
Heart failure society of america
Gaylord national harbor convention center
Meeting of the american society gene
Rocket pharmaceuticals inc
Rocket pharmaceuticals
Disease trial
Heart failure society
Annual scientific meeting
Annual meeting
American society
Cell therapy
Safety profile
First pediatric cardiomyopathy gene therapy trial
Danon disease
vimarsana © 2020. All Rights Reserved.